Avoro Capital Advisors LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Centessa Pharmaceuticals plc Ordinary shares, nominal value 0.002 GBP per share (CNTA)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: Centessa Pharmaceuticals plc Ordinary shares, nominal value 0.002 GBP per share
Symbol: CNTA
Shares outstanding: 145,993,531 shares
Disclosed Ownership: 14,555,555 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 09:04:25 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	10%	14,555,555	14,555,555	0	/s/ Scott Epstein	Scott Epstein, Chief Operating Officer and Chief Compliance Officer
Behzad Aghazadeh	10%	14,555,555	14,555,555	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually